Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Jungsil Ro, MD
Woman Max 99 years
Jungsil Ro, MD,PhD
Update Il y a 4 ans
Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC
Primary objective is to evaluate the response rates and clinical benefits of letrozole + goserelin in premenopausal patients versus letrozole alone in postmenopausal patients with metastat...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, MD
Update Il y a 4 ans
Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)
Primary objectives : 1. To evaluate the recommended dose of the combination of paclitaxel, gemcitabine, and lapatinib (Tykerb®) (PGT) as preoperative chemotherapy in patients with HER2 po...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, MD,PhD
Update Il y a 4 ans
Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer
This is an open labeled phase III randomized trial. The patients with clinical stage II and III will undergo mammotome biopsy of breast tumor for histologic diagnosis, immunohistochemical ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, MD,PhD
Update Il y a 4 ans
Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab
To evaluate the pathologic complete response rate to preoperative administration of Paclitaxel, Gemcitabine, and Trastuzumab (HerceptinÒ) (PGH)
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, MD, PhD
Update Il y a 4 ans
Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer
To evaluate the overall response rate of gemcitabine and vinorelbine combination (GV) and gemcitabine followed by vinorelbine (G⇒V) when used as palliative therapy in patients with stage I...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, MD, PhD
Update Il y a 4 ans
Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
This is an open labeled phase II single arm trial. The patients with clinical stage II and III will undergo core-needle biopsy of breast tumor for histologic diagnosis, immunohistochemical...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Jungsil Ro, MD, PhD
Update Il y a 4 ans
Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen
Primary objectives of this study is to evaluate the effects of CYP2D6 genotypes on time to progression after tamoxifen treatment in pre- or postmenopausal women with metastatic breast canc...
Country
Korea, Republic of
organs
None
Specialty
None
Closed trial
More information